Pharmacological therapeutics in Friedreich ataxia: the present state
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological therapeutics in Friedreich ataxia: the present state
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 17, Issue 9, Pages 895-907
Publisher
Informa UK Limited
Online
2017-07-20
DOI
10.1080/14737175.2017.1356721
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans
- (2017) Genki Hayashi et al. HUMAN MOLECULAR GENETICS
- Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
- (2017) Valentina Sardone et al. MOLECULES
- Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo
- (2017) James L. Miller et al. NEUROPHARMACOLOGY
- E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia
- (2017) Monica Benini et al. Cell Reports
- Selected missense mutations impair frataxin processing in Friedreich ataxia
- (2017) Elisia Clark et al. Annals of Clinical and Translational Neurology
- Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia
- (2016) S. Chiang et al. CLINICAL SCIENCE
- Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia
- (2016) D L Ouellet et al. GENE THERAPY
- Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia
- (2016) Antonio Costantini et al. JOURNAL OF NEUROLOGY
- Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study
- (2016) Kathrin Reetz et al. LANCET NEUROLOGY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor
- (2016) Yogesh K. Chutake et al. NUCLEIC ACIDS RESEARCH
- Activating frataxin expression by repeat-targeted nucleic acids
- (2016) Liande Li et al. Nature Communications
- Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia
- (2016) Joseph F. Nabhan et al. Scientific Reports
- Progression of Friedreich ataxia: quantitative characterization over 5 years
- (2016) Maya Patel et al. Annals of Clinical and Translational Neurology
- Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation
- (2016) Arnulf H. Koeppen et al. Acta Neuropathologica Communications
- An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
- (2015) Eppie M. Yiu et al. JOURNAL OF NEUROLOGY
- Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data
- (2015) Kathrin Reetz et al. LANCET NEUROLOGY
- Excision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia
- (2015) Yanjie Li et al. MOLECULAR THERAPY
- Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells
- (2015) Alessandra Rufini et al. NEUROBIOLOGY OF DISEASE
- GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients
- (2015) Christian Marcotulli et al. NEUROLOGICAL SCIENCES
- Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test
- (2015) Marika Pane et al. NEUROMUSCULAR DISORDERS
- Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia
- (2015) Rosella Abeti et al. PHARMACOLOGICAL RESEARCH
- The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
- (2015) Arnulf H. Koeppen et al. PLoS One
- Perturbation of cellular proteostasis networks identifies pathways that modulate precursor and intermediate but not mature levels of frataxin
- (2015) Joseph F. Nabhan et al. Scientific Reports
- RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
- (2015) Brandon L. Probst et al. PLoS One
- Open-label pilot study of interferon gamma-1b in Friedreich ataxia
- (2014) L. Seyer et al. ACTA NEUROLOGICA SCANDINAVICA
- Epigenetic therapy for Friedreich ataxia
- (2014) Elisabetta Soragni et al. ANNALS OF NEUROLOGY
- Therapeutic approaches for the treatment of Friedreich’s ataxia
- (2014) Cassandra J Strawser et al. Expert Review of Neurotherapeutics
- Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia
- (2014) Sunil Sahdeo et al. HUMAN MOLECULAR GENETICS
- Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study
- (2014) Vincenzo Libri et al. LANCET
- Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution?
- (2014) James Smoliga et al. MOLECULES
- Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia
- (2014) Sylvia Boesch et al. MOVEMENT DISORDERS
- Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia
- (2014) Morgane Perdomini et al. NATURE MEDICINE
- R-loops Associated with Triplet Repeat Expansions Promote Gene Silencing in Friedreich Ataxia and Fragile X Syndrome
- (2014) Matthias Groh et al. PLoS Genetics
- An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models
- (2014) Catherine Gérard et al. Molecular Therapy-Methods & Clinical Development
- Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial
- (2013) J. Arpa et al. ACTA NEUROLOGICA SCANDINAVICA
- Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model
- (2013) Yuxi Shan et al. ANTIOXIDANTS & REDOX SIGNALING
- Rating disease progression of Friedreich’s ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database
- (2013) Günther Metz et al. BRAIN
- Friedreich Ataxia: Executive Control Is Related to Disease Onset and GAA Repeat Length
- (2013) Wolfgang Nachbauer et al. CEREBELLUM
- Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3
- (2013) P. K. Chan et al. HUMAN MOLECULAR GENETICS
- Frataxin Deficiency Leads to Reduced Expression and Impaired Translocation of NF-E2-Related Factor (Nrf2) in Cultured Motor Neurons
- (2013) Valentina D'Oria et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-enzyme Q10and idebenone use in Friedreich's ataxia
- (2013) Michael H Parkinson et al. JOURNAL OF NEUROCHEMISTRY
- Mitochondrial pathophysiology in Friedreich's ataxia
- (2013) Pilar González-Cabo et al. JOURNAL OF NEUROCHEMISTRY
- Deferiprone for the treatment of Friedreich's ataxia
- (2013) Massimo Pandolfo et al. JOURNAL OF NEUROCHEMISTRY
- Clinical features of Friedreich's ataxia: classical and atypical phenotypes
- (2013) Michael H. Parkinson et al. JOURNAL OF NEUROCHEMISTRY
- A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins
- (2013) Pierre Chapdelaine et al. Molecular Therapy-Nucleic Acids
- Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids
- (2013) M. Grazia Cotticelli et al. Redox Biology
- Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model
- (2012) Hyunjin Vincent Kim et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Effect of EPI-743 on the Clinical Course of the Mitochondrial Disease Leber Hereditary Optic Neuropathy
- (2012) Alfredo A. Sadun ARCHIVES OF NEUROLOGY
- Tat-Frataxin protects dopaminergic neuronal cells against MPTP-induced toxicity in a mouse model of Parkinson's disease
- (2012) Mi Jin Kim et al. BIOCHIMIE
- Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
- (2012) B. Tomassini et al. HUMAN MOLECULAR GENETICS
- Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia
- (2012) Elisabetta Soragni et al. JOURNAL OF CHILD NEUROLOGY
- EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh Syndrome
- (2012) Diego Martinelli et al. MOLECULAR GENETICS AND METABOLISM
- Erythropoietin in Friedreich ataxia: No effect on frataxin in a randomized controlled trial
- (2012) Caterina Mariotti et al. MOVEMENT DISORDERS
- A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial
- (2012) David R. Lynch et al. MOVEMENT DISORDERS
- Glucocorticoid Analogues: Potential Therapeutic Alternatives for Treating Inflammatory Muscle Diseases
- (2012) Erica K.M. Reeves et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)
- (2011) Sarah J. Lagedrost et al. AMERICAN HEART JOURNAL
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- Effects of Erythropoietin on Frataxin Levels and Mitochondrial Function in Friedreich Ataxia – a Dose–Response Trial
- (2011) Wolfgang Nachbauer et al. CEREBELLUM
- Infectious delivery and long-term persistence of transgene expression in the brain by a 135-kb iBAC-FXN genomic DNA expression vector
- (2011) A Gimenez-Cassina et al. GENE THERAPY
- A TAT–Frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model
- (2011) Piyush M. Vyas et al. HUMAN MOLECULAR GENETICS
- Mortality in Friedreich Ataxia
- (2011) Amy Y. Tsou et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Initial experience in the treatment of inherited mitochondrial disease with EPI-743
- (2011) Gregory M. Enns et al. MOLECULAR GENETICS AND METABOLISM
- Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease
- (2011) Mikhail S. Shchepinov et al. TOXICOLOGY LETTERS
- A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
- (2010) David R. Lynch et al. ARCHIVES OF NEUROLOGY
- Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia
- (2010) Daniel Velasco-Sánchez et al. CEREBELLUM
- Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit
- (2010) Francesco Saccà et al. MOVEMENT DISORDERS
- Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design
- (2010) Lisa S. Friedman et al. MOVEMENT DISORDERS
- PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia
- (2010) Daniele Marmolino et al. PLoS One
- Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich’s ataxia
- (2009) Giovanni Coppola et al. HUMAN MOLECULAR GENETICS
- Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus
- (2009) In Koo Hwang et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Comparison of three clinical rating scales in Friedreich ataxia (FRDA)
- (2009) Katrin Bürk et al. MOVEMENT DISORDERS
- Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia
- (2009) Vincent Paupe et al. PLoS One
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
- (2009) Pei-Chun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Idebenone treatment in paediatric and adult patients with Friedreich ataxia: Long-term follow-up
- (2008) Mercè Pineda et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: A clinical pilot trial
- (2008) Sylvia Boesch et al. MOVEMENT DISORDERS
- HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
- (2008) Myriam Rai et al. PLoS One
- Antioxidant use in Friedreich ataxia
- (2007) Lauren Myers et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now